Skip to main content
. 2020 Jun 27;15(4):284–291. doi: 10.1016/j.jtumed.2020.05.003

Table 1.

Characteristics of participants.

Variables Group I (n = 25) Group II (n = 76) P value
Sex
Male: Female 12:13 30:46 0.453
Age (years) 51.0 ± 10.9 43.4 ± 8.9 0.003
Body mass index (kg/m2) 31.5 33.7 ± 5.7 0.072
Waist circumference (cm) 106.5 ± 12.3 107.1 ± 9.6 0.810
Waist-to-height ratio 0.656 ± 0.070 0.651 ± 0.086 0.814
Triglyceride index 1.256 ± 0.650 1.057 ± 0.521 0.171
Cholesterol index 0.880 ± 0.196 0.929 ± 0.159 0.260
Diabetes (no.) 10 17 0.084
Fasting serum glucose (non-diabetic) 118.2 ± 30.1 107.6 ± 16.3 0.203
Fasting serum glucose (diabetic) 146.3 ± 69.6 156.7 ± 42.7 0.841
Alanine aminotransferase (U/L) 19.1 ± 5.7 42.4 ± 21.3 <0.001
Aspartate aminotransferase (U/L) 18.9 ± 4.3 28.5 ± 13.5 <0.001
Alanine/aspartate aminotransferase ratio 1.053 ± 0.383 1.593 ± 0.582 <0.001
Aspartate/alanine aminotransferase ratio 1.075 ± 0.389 0.720 ± 0.279 <0.001

The results are presented as mean ± SD. P values were calculated using the two-tailed independent two-sample t-test for continuous data, and the Chi-square test for discrete data. Group I: patients with risk factors, Group II: patients with non-alcoholic fatty liver disease.